Search Results - "GOOLEY, Theodore A"

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood by Brunstein, Claudio G., Gutman, Jonathan A., Weisdorf, Daniel J., Woolfrey, Ann E., DeFor, Todd E., Gooley, Theodore A., Verneris, Michael R., Appelbaum, Frederick R., Wagner, John E., Delaney, Colleen

“…Effectiveness of double umbilical cord blood (dUCB) grafts relative to conventional marrow and mobilized peripheral blood from related and unrelated donors has…”
Get full text

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer by DISIS, Mary L, WALLACE, Danelle R, DELA ROSA, Corazon, TIETJE, Kathleen, LINK, John, WAISMAN, James, SALAZAR, Lupe G, GOOLEY, Theodore A, YUSHE DANG, SLOTA, Meredith, HAILING LU, COVELER, Andrew L, CHILDS, Jennifer S, HIGGINS, Doreen M, FINTAK, Patricia A

“…The primary objectives of this phase I/II study were to evaluate the safety and immunogenicity of combination therapy consisting of concurrent trastuzumab and…”
Get full text

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality by Sorror, Mohamed L., Martin, Paul J., Storb, Rainer F., Bhatia, Smita, Maziarz, Richard T., Pulsipher, Michael A., Maris, Michael B., Davis, Christopher, Deeg, H. Joachim, Lee, Stephanie J., Maloney, David G., Sandmaier, Brenda M., Appelbaum, Frederick R., Gooley, Theodore A.

“…Whether the hematopoietic cell transplantation comorbidity index (HCT-CI) can provide prognostic information about development of acute graft-versus-host…”
Get full text

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome–positive leukemia by Carpenter, Paul A., Snyder, David S., Flowers, Mary E.D., Sanders, Jean E., Gooley, Theodore A., Martin, Paul J., Appelbaum, Frederick R., Radich, Jerald P.

“…Relapse occurs frequently after allogeneic hematopoietic cell transplantation (HCT) for treatment of high-risk Philadelphia chromosome–positive (Ph+) leukemia…”
Get full text

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model by Green, Damian J., Shadman, Mazyar, Jones, Jon C., Frayo, Shani L., Kenoyer, Aimee L., Hylarides, Mark D., Hamlin, Donald K., Wilbur, D. Scott, Balkan, Ethan R., Lin, Yukang, Miller, Brian W., Frost, Sofia.H.L., Gopal, Ajay K., Orozco, Johnnie J., Gooley, Theodore A., Laird, Kelly L., Till, Brian G., Bäck, Tom, Sandmaier, Brenda M., Pagel, John M., Press, Oliver W.

“…α-Emitting radionuclides deposit a large amount of energy within a few cell diameters and may be particularly effective for radioimmunotherapy targeting…”
Get full text

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study by Nash, Richard A., McSweeney, Peter A., Crofford, Leslie J., Abidi, Muneer, Chen, Chien-Shing, Godwin, J. David, Gooley, Theodore A., Holmberg, Leona, Henstorf, Gretchen, LeMaistre, C. Fred, Mayes, Maureen D., McDonagh, Kevin T., McLaughlin, Bernadette, Molitor, Jerry A., Nelson, J. Lee, Shulman, Howard, Storb, Rainer, Viganego, Federico, Wener, Mark H., Seibold, James R., Sullivan, Keith M., Furst, Daniel E.

“…More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose…”
Get full text

The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation by Shaw, Bronwen E., Gooley, Theodore A., Malkki, Mari, Madrigal, J. Alejandro, Begovich, Ann B., Horowitz, Mary M., Gratwohl, Alois, Ringdén, Olle, Marsh, Steven G.E., Petersdorf, Effie W.

“…Hematopoietic cell transplantation (HCT) from an HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 allele–matched unrelated donor is a well-recognized life-saving…”
Get full text

MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation by Petersdorf, Effie W, Malkki, Mari, Gooley, Theodore A, Spellman, Stephen R, Haagenson, Michael D, Horowitz, Mary M, Wang, Tao

“…Blood malignancies can be cured with hematopoietic cell transplantation from human leukocyte antigen (HLA)-matched unrelated donors; however, acute…”
Get more information

Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines by DISIS, Mary L, GOOLEY, Theodore A, RINN, Kristine, DAVIS, Donna, PIEPKORN, Michael, CHEEVER, Martin A, KNUTSON, Keith L, SCHIFFMAN, Kathy

“…The HER-2/neu protein is a nonmutated tumor antigen that is overexpressed in a variety of human malignancies, including breast and ovarian cancer. Many tumor…”
Get full text

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by Randolph, SophiaS.B., Gooley, Theodore A., Warren, Edus H., Appelbaum, Frederick R., Riddell, Stanley R.

“…Male recipients of transplants from female (F→M) hematopoietic stem cell donors represent a special group in whom donor T cells that are specific for recipient…”
Get full text

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients by Turtle, Cameron J, Hanafi, Laïla-Aïcha, Berger, Carolina, Gooley, Theodore A, Cherian, Sindhu, Hudecek, Michael, Sommermeyer, Daniel, Melville, Katherine, Pender, Barbara, Budiarto, Tanya M, Robinson, Emily, Steevens, Natalia N, Chaney, Colette, Soma, Lorinda, Chen, Xueyan, Yeung, Cecilia, Wood, Brent, Li, Daniel, Cao, Jianhong, Heimfeld, Shelly, Jensen, Michael C, Riddell, Stanley R, Maloney, David G

“…T cells that have been modified to express a CD19-specific chimeric antigen receptor (CAR) have antitumor activity in B cell malignancies; however,…”
Get full text

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations by Pagel, John M., Orgun, Nural, Hamlin, Donald K., Wilbur, D. Scott, Gooley, Theodore A., Gopal, Ajay K., Park, Steven I., Green, Damian J., Lin, Yukang, Press, Oliver W.

“…Relapsed B-cell lymphomas are currently incurable with conventional chemotherapy and radiation treatments. Radiolabeled antibodies directed against B-cell…”
Get full text

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis by Gopal, Ajay K., Gooley, Theodore A., Maloney, David G., Petersdorf, Stephen H., Eary, Janet F., Rajendran, Joseph G., Bush, Sharon A., Durack, Lawrence D., Golden, Jane, Martin, Paul J., Matthews, Dana C., Appelbaum, Frederick R., Bernstein, Irwin D., Press, Oliver W.

“…We performed a multivariable comparison of 125 consecutive patients with follicular lymphoma (FL) treated at our centers with either high-dose…”
Get full text

Ablative Allogeneic Hematopoietic Cell Transplantation in Adults 60 Years of Age and Older by WALLEN, Herschel, GOOLEY, Theodore A, DEEG, H. Joachim, PAGEL, John M, PRESS, Oliver W, APPELBAUM, Frederick R, STORB, Rainer, GOPAL, Ajay K

“…To evaluate outcomes of ablative allogeneic hematopoietic cell transplantation (HCT) in older patients with hematologic malignancies. We treated 52 patients…”
Get full text

HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis by Perlman, Jordan E, Gooley, Theodore A, McNulty, Bridget, Meyers, Jedidiah, Hirsch, Irl B

“…There can be marked discordance between laboratory and estimated (using the glucose management indicator [GMI]) glycated hemoglobin (HbA1c) from continuous…”
Get more information

Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques by Berger, Carolina, Berger, Michael, Beard, Brian C, Kiem, Hans-Peter, Gooley, Theodore A, Riddell, Stanley R

“…The adoptive transfer of antigen-specific effector T cells is being used to treat human infections and malignancy. T cell persistence is a prerequisite for…”
Get full text

High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes by McSweeney, Peter A., Nash, Richard A., Sullivan, Keith M., Storek, Jan, Crofford, Leslie J., Dansey, Roger, Mayes, Maureen D., McDonagh, Kevin T., Nelson, J. Lee, Gooley, Theodore A., Holmberg, Leona A., Chen, C.S., Wener, Mark H., Ryan, Katherine, Sunderhaus, Julie, Russell, Ken, Rambharose, John, Storb, Rainer, Furst, Daniel E.

“…Systemic sclerosis (SSc) is a multisystem disease of presumed autoimmune pathogenesis for which no proven effective treatment exists. High-dose…”
Get full text

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation by Giaccone, Luisa, McCune, Jeannine S., Maris, Michael B., Gooley, Theodore A., Sandmaier, Brenda M., Slattery, John T., Cole, Scott, Nash, Richard A., Storb, Rainer F., Georges, George E.

“…The immunosuppressive drug mycophenolate mofetil (MMF) is used after nonmyeloablative hematopoietic cell transplantation (HCT); however, limited…”
Get full text

Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease by Bleakley, Marie, Sehgal, Alison, Seropian, Stuart, Biernacki, Melinda A, Krakow, Elizabeth F, Dahlberg, Ann, Persinger, Heather, Hilzinger, Barbara, Martin, Paul J, Carpenter, Paul A, Flowers, Mary E, Voutsinas, Jenna, Gooley, Theodore A, Loeb, Keith, Wood, Brent L, Heimfeld, Shelly, Riddell, Stanley R, Shlomchik, Warren D

“…Graft-versus-host disease (GVHD) causes morbidity and mortality following allogeneic hematopoietic cell transplantation. Naive T cells (T ) cause severe GVHD…”
Get full text

Immunization of Cancer Patients with HER-2/neu-Derived Peptides Demonstrating High-Affinity Binding to Multiple Class II Alleles by SALAZAR, Lupe G, FIKES, John, SOUTHWOOD, Scott, ISHIOKA, Glenn, KNUTSON, Keith L, GOOLEY, Theodore A, SCHIFFMAN, Kathy, DISIS, Mary L

“…Purpose: The purpose of this study was to immunize patients with HER-2/ neu -overexpressing cancer with a multipeptide vaccine comprised of four class II…”
Get full text